Taysha Gene Therapies (TSHA) Q1 2025 Earnings

26FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.16
-0.13
-0.1
-0.07

Details

Expected EPS
-0.081308
Actual EPS
-0.07
Surprise EPS
0.01
Surprise Percent
+13.91%

Description

Taysha Gene Therapies (TSHA) has reported earnings of -0.07 per share for Q1 2025.

0 Comments

Share your thoughts